Citadel Advisors - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 6 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$59,014,000
-65.8%
27,000,000
-21.9%
0.02%
-72.6%
Q2 2020$172,606,000
+238.5%
34,560,0000.0%0.06%
+169.6%
Q1 2020$50,984,00034,560,0000.02%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
AQR Arbitrage LLC 5,000,000$4,571,0000.12%
WOLVERINE ASSET MANAGEMENT LLC 6,415,000$6,081,0000.06%
D. E. Shaw & Co., Inc. 5,000,000$5,726,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders